Literature DB >> 6188918

Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity.

A J Man in 't Veld, M A Schalekamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6188918     DOI： 10.1097/00005344-198300051-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN： 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  16 in total

1.  Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.

Authors:  J M Rapola; T J Pellinen; P Koskinen; L Toivonen; M S Nieminen
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 2.  ISA--vasodilatation: improvement of organ perfusion.

Authors:  L Hansson
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

3.  [How many beta-receptor blockers does the physician need?].

Authors:  D Palm
Journal:  Klin Wochenschr       Date:  1987-03-16

4.  Propranolol and atenolol inhibit norepinephrine spillover rate into plasma in conscious spontaneously hypertensive rats.

Authors:  T K Keeton; A M Biediger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

5.  The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.

Authors:  D Taverner; I G Mackay; K Craig; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

6.  Comparison of the onset of the antihypertensive action of pindolol and propranolol. A 24 h haemodynamic study.

Authors:  A H van den Meiracker; A J Man in't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

7.  Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients.

Authors:  K Winther; J B Knudsen; J Gormsen; J Jensen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Is the feeling of cold extremities experienced by hypertensive patients due to their disease or their treatment?

Authors:  M J VandenBurg; S J Evans; W D Cooper; F Bradshaw; W J Currie
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.

Authors:  B Dahlöf; M Danielson; O Andersson; T Thulin; P Ohman; C Mörlin; J Boberg; B E Karlberg; S Jern; L Hansson
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

10.  Acute systemic and antiischemic effects of epanolol in patients with coronary artery disease.

Authors:  E H Venneker; W J Remme; D C van Hoogenhuyze; X H Krauss; G L Bartels; D A Kruijssen; C J Storm; D van Schelven
Journal:  Cardiovasc Drugs Ther       Date:  1994-04       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.